Dolby Laboratories, Inc. DLB Balance Sheet Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| $673.81M-10.2% | $727.57M+18.9% | $793.36M+37.3% | $756.56M+2.0% | $750.34M+5.8% | ||
| $460K— | —— | —— | —— | —— | ||
| $640.44M+16.2% | $579.56M+2.4% | $519.22M+0.2% | $509.21M+5.8% | $551.09M+3.7% | ||
| $31.93M-7.7% | $31.26M-1.8% | $30.42M-9.8% | $32.42M-6.6% | $34.59M-3.4% | ||
| $1.41B+1.8% | $1.41B+9.5% | $1.39B+16.2% | $1.34B-8.9% | $1.39B-10.5% | ||
| $461.84M-2.3% | $466.72M-2.0% | $470.61M-1.8% | $478.48M+0.2% | $472.66M-1.8% | ||
| $529.67M+0.9% | $530.3M+1.9% | $529.9M-0.6% | $528.82M+29.5% | $525.02M+28.5% | ||
| $389.71M-5.4% | $364.02M-13.6% | $397.06M-8.6% | $408.15M+182% | $412.06M+171% | ||
| $81.22M+10.1% | $85.02M-1.5% | $80.21M-10.2% | $78.02M-33.8% | $73.76M-42.4% | ||
| $3.25B+0.6% | $3.19B+1.1% | $3.23B+3.8% | $3.2B+7.5% | $3.23B+6.1% | ||
| $20.69M+19.7% | $8.67M-25.0% | $17.84M+2.6% | $17.23M+5.0% | $17.29M-12.4% | ||
| $38.84M-2.0% | $37.09M0.0% | $31.38M-0.8% | $36.03M+10.4% | $39.62M+5.1% | ||
| $474.61M+3.7% | $443.51M+0.4% | $437.79M+4.8% | $388.79M+9.7% | $457.49M+3.3% | ||
| $622.36M-3.7% | $589.25M-8.2% | $595.81M-4.4% | $581.75M+10.6% | $646.02M+6.4% | ||
| $2.63B+1.1% | $2.6B+2.4% | $2.63B+5.6% | $2.62B+6.3% | $2.6B+6.2% | ||
| $2.62B+1.7% | $2.59B+3.4% | $2.62B+5.9% | $2.6B+7.1% | $2.57B+6.3% | ||
| $3.25B+0.6% | $3.19B+1.1% | $3.23B+3.8% | $3.2B+7.5% | $3.23B+6.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Dolby Laboratories, Inc. cover its short-term obligations?
- Its current ratio is 2.98 — current assets exceed current liabilities.
- Where does Dolby Laboratories, Inc.'s balance sheet data come from?
- Every line is extracted from Dolby Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.